Literature DB >> 20186545

[The IOL-Vip system : Principles and clinical application].

R Khoramnia1, C W von Mohrenfels, J P Salgado, B Schweiger, M Engel, J Hadeler, C P Lohmann.   

Abstract

There are various retinal disorders that cause macular degeneration. However, age-related macular degeneration (ARMD) is the main cause of legal blindness in developed countries. Even today the end stage of this disease can often not be avoided. Patients suffer from central scotoma and severe vision loss. Low vision aids may help in certain situations, but these devices are often functionally and cosmetically inadequate. The implantation of the IOL-Vip system is a new surgical alternative. The lens system consists of a high negative power lens (-64 D) which is implanted in the capsular bag and a high positive power lens (+53 D) which is implanted in the anterior chamber. An intraocular Galilean telescope is reproduced by this arrangement. The IOL-Vip system provides a magnification of 1.3 without notably compromising the peripheral visual field. Investigations have shown that visual improvement can be achieved after implantation of the IOL-Vip system combined with a rehabilitation program. In particular orientation and the ability of patients to perform everyday tasks showed improvement.

Entities:  

Mesh:

Year:  2010        PMID: 20186545     DOI: 10.1007/s00347-009-2094-y

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  22 in total

1.  A prospective multicenter clinical trial to evaluate the safety and effectiveness of the implantable miniature telescope.

Authors:  S S Lane; B D Kuppermann; I H Fine; M B Hamill; J F Gordon; R S Chuck; R S Hoffman; M Packer; D D Koch
Journal:  Am J Ophthalmol       Date:  2004-06       Impact factor: 5.258

Review 2.  Surgical treatment of low vision.

Authors:  John Gorfinkel
Journal:  Can J Ophthalmol       Date:  2006-06       Impact factor: 1.882

Review 3.  The Implantable Miniature Telescope for macular degeneration.

Authors:  Stephen S Lane; Baruch D Kuppermann
Journal:  Curr Opin Ophthalmol       Date:  2006-02       Impact factor: 3.761

4.  [Quality of life by limited vision in old age: the example of age-related macula degeneration].

Authors:  H-W Wahl; V Heyl; N Langer
Journal:  Ophthalmologe       Date:  2008-08       Impact factor: 1.059

5.  [Quality control in rehabilitation of patients with visual impairment: evaluation of use and benefits of optic and electronic devices].

Authors:  S J Fröhlich; C A Lackerbauer
Journal:  Ophthalmologe       Date:  2006-12       Impact factor: 1.059

6.  Psychophysics of reading. XVII. Low-vision performance with four types of electronically magnified text.

Authors:  S Harland; G E Legge; A Luebker
Journal:  Optom Vis Sci       Date:  1998-03       Impact factor: 1.973

7.  Medium-term results of implantable miniaturized telescopes in eyes with age-related macular degeneration.

Authors:  M Kaşkaloğlu; O Uretmen; A Yağci
Journal:  J Cataract Refract Surg       Date:  2001-11       Impact factor: 3.351

8.  Vision-related quality of life in patients with bilateral severe age-related macular degeneration.

Authors:  Mark T Cahill; Avie D Banks; Sandra S Stinnett; Cynthia A Toth
Journal:  Ophthalmology       Date:  2005-01       Impact factor: 12.079

9.  The IOL-Vip System: a double intraocular lens implant for visual rehabilitation of patients with macular disease.

Authors:  Nicola Orzalesi; Chiara O Pierrottet; Stefano Zenoni; Claudio Savaresi
Journal:  Ophthalmology       Date:  2007-05       Impact factor: 12.079

10.  Clinical magnification and residual refraction after implantation of a double intraocular lens system in patients with macular degeneration.

Authors:  Luis Amselem; Manuel Diaz-Llopis; Adelina Felipe; Jose M Artigas; Amparo Navea; Salvador García-Delpech
Journal:  J Cataract Refract Surg       Date:  2008-09       Impact factor: 3.351

View more
  1 in total

Review 1.  Current Approaches to Low Vision (Re)Habilitation

Authors:  Deniz Altınbay; Şefay Aysun İdil
Journal:  Turk J Ophthalmol       Date:  2019-06-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.